Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
RMD Open
|
November 13, 2024
Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial
Johanna Elin Gehin, Rolf Anton Klaasen, Eirik Klami Kristianslund, et al.
Rheumatology (Oxford, England)
|
September 29, 2023
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases
Ingrid Jyssum, Johanna E Gehin, Joseph Sexton, et al.
The Journal of Organic Chemistry
|
August 1, 2023
Diastereoselective and Scalable Synthesis of 6-(<i>S</i>)-Hydroxycannabidivarin
Hannah V Stone, Frederick J Topping, Alberte X Veiga, et al.
Zootaxa
|
April 12, 2023
Earthworms (Clitellata, Megadrili) of the world: an updated checklist of valid species and families, with notes on their distribution
Mete Misirlioğlu, John Warren Reynolds, Mirjana Stojanović, et al.
Gut
|
February 26, 2025
Serological screening for coeliac disease in an adult general population: the HUNT study
Ina Lervåg Andersen, Polina Lukina, Ole T Dyrli, et al.
The Lancet. Rheumatology
|
February 25, 2024
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials
Marthe Kirkesæther Brun, Johanna E Gehin, Kristin Hammersbøen Bjørlykke, et al.
Journal of Internal Medicine
|
April 12, 2022
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial
Marthe Kirkesaether Brun, Guro Løvik Goll, Kristin Kaasen Jørgensen, et al.
Elife
|
May 23, 2019
Mechanism of completion of peptidyltransferase centre assembly in eukaryotes
Vasileios Kargas, Pablo Castro-Hartmann, Norberto Escudero-Urquijo, et al.
Journal of Internal Medicine
|
February 27, 2023
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases
Marthe Kirkesaether Brun, Kristin Hammersbøen Bjørlykke, Marte K Viken, et al.
The Journal of Urology
|
March 11, 2005
A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis
Robert Mayer, Kathleen Joy Propert, Kenneth M Peters, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
RMD Open
|
November 13, 2024
Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial
Johanna Elin Gehin, Rolf Anton Klaasen, Eirik Klami Kristianslund, et al.
Rheumatology (Oxford, England)
|
September 29, 2023
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases
Ingrid Jyssum, Johanna E Gehin, Joseph Sexton, et al.
The Journal of Organic Chemistry
|
August 1, 2023
Diastereoselective and Scalable Synthesis of 6-(<i>S</i>)-Hydroxycannabidivarin
Hannah V Stone, Frederick J Topping, Alberte X Veiga, et al.
Zootaxa
|
April 12, 2023
Earthworms (Clitellata, Megadrili) of the world: an updated checklist of valid species and families, with notes on their distribution
Mete Misirlioğlu, John Warren Reynolds, Mirjana Stojanović, et al.
Gut
|
February 26, 2025
Serological screening for coeliac disease in an adult general population: the HUNT study
Ina Lervåg Andersen, Polina Lukina, Ole T Dyrli, et al.
The Lancet. Rheumatology
|
February 25, 2024
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials
Marthe Kirkesæther Brun, Johanna E Gehin, Kristin Hammersbøen Bjørlykke, et al.
Journal of Internal Medicine
|
April 12, 2022
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial
Marthe Kirkesaether Brun, Guro Løvik Goll, Kristin Kaasen Jørgensen, et al.
Elife
|
May 23, 2019
Mechanism of completion of peptidyltransferase centre assembly in eukaryotes
Vasileios Kargas, Pablo Castro-Hartmann, Norberto Escudero-Urquijo, et al.
Journal of Internal Medicine
|
February 27, 2023
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases
Marthe Kirkesaether Brun, Kristin Hammersbøen Bjørlykke, Marte K Viken, et al.
The Journal of Urology
|
March 11, 2005
A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis
Robert Mayer, Kathleen Joy Propert, Kenneth M Peters, et al.
Page
of 11